|
|
Volumn 476, Issue 7360, 2011, Pages 260-261
|
|
HIV drug-prevention strategy carries risks
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
SILDENAFIL;
CONSENSUS DEVELOPMENT;
COST EFFECTIVENESS ANALYSIS;
CROSS INFECTION;
DRUG COST;
FOOD AND DRUG ADMINISTRATION;
HIGH RISK BEHAVIOR;
HIGH RISK POPULATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NOTE;
PRE EXPOSURE PROPHYLAXIS;
PRIORITY JOURNAL;
PROPHYLAXIS;
PUBLIC HEALTH SERVICE;
RISK DISINHIBITION;
CHEMOPREVENTION;
CLINICAL TRIALS AS TOPIC;
DEOXYCYTIDINE;
DRUG COMBINATIONS;
FEMALE;
HEALTH;
HIV INFECTIONS;
HUMANS;
MALE;
ORGANOPHOSPHORUS COMPOUNDS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
UNSAFE SEX;
|
|
EID: 80051936713
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/476260a Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
